These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18441003)

  • 21. An unusual case of urticaria and nephrotic syndrome.
    Wiederkehr MR; Nicosia RF; Munschauer C; Moe OW
    Am J Kidney Dis; 2006 Sep; 48(3):506-12. PubMed ID: 16931227
    [No Abstract]   [Full Text] [Related]  

  • 22. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
    Oh J; Kemper MJ
    Minerva Pediatr; 2012 Apr; 64(2):197-204. PubMed ID: 22495193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?
    Smith GC
    Pediatr Nephrol; 2007 Jun; 22(6):893-8. PubMed ID: 17310362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the treatment of adult nephrotic syndrome].
    Yokoyama H; Asaka M; Yamaya H; Wada T
    Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
    [No Abstract]   [Full Text] [Related]  

  • 25. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
    Leichtman AB
    N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric steroid-resistant nephrotic syndrome.
    McBryde KD; Kershaw DB; Smoyer WE
    Curr Probl Pediatr Adolesc Health Care; 2001 Oct; 31(9):280-307. PubMed ID: 11733743
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituximab followed by mycophenolate mofetil in children with IgM nephropathy.
    Gu J; Xia Y; Mao J; Fu H; Liu A
    Indian Pediatr; 2012 Oct; 49(10):831-3. PubMed ID: 23144102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Membranous nephropathy].
    Yokoyama H; Yoshimoto K; Wada T
    Nihon Rinsho; 2004 Oct; 62(10):1856-60. PubMed ID: 15500130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latest treatment strategies for membranous nephropathy.
    Ruggenenti P; Cravedi P; Remuzzi G
    Expert Opin Pharmacother; 2007 Dec; 8(18):3159-71. PubMed ID: 18035960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y; Tomino Y
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving treatment strategies for inflammatory bowel disease.
    Hanauer SB; Dassopoulos T
    Annu Rev Med; 2001; 52():299-318. PubMed ID: 11160781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for childhood-onset nephrotic syndrome.
    Hodson EM; Craig JC
    Lancet; 2014 Oct; 384(9950):1242-3. PubMed ID: 24965824
    [No Abstract]   [Full Text] [Related]  

  • 35. Differing proteinuria control with cyclosporin and tacrolimus.
    Krämer BK; Schweda F
    Lancet; 1997 Mar; 349(9056):953-4. PubMed ID: 9093272
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
    Lorillon G; Robin M; Meignin V; Ribaud P; Lescoeur B; Gossot D; Socié G; Tazi A; Bergeron A
    Eur Respir J; 2011 Aug; 38(2):470-2. PubMed ID: 21804164
    [No Abstract]   [Full Text] [Related]  

  • 38. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
    Sellier-Leclerc AL; Baudouin V; Kwon T; Macher MA; Guérin V; Lapillonne H; Deschênes G; Ulinski T
    Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacotherapy of SLE].
    Nakazawa T; Kumagai S; Kogata Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].
    Yoshida M
    Nihon Jinzo Gakkai Shi; 2010; 52(1):1-9. PubMed ID: 20166533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.